Furthermore, the low expression of Survivin is considered to be one of the factors for the success of chemotherapy; Bmi-1 promotes the drug resistance of B-cell lymphoma cells through the regulation of Survivin [171]. The gene discussed is BMI1; the disease is B-cell non-Hodgkin lymphoma.